Investor Relations

Recent Event

2022 Annual Meeting of Stockholders

Latest Financial Results

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2021

Company Overview

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting the endocannabinoid system. Artelo is rapidly advancing a portfolio of broadly applicable product candidates designed to address significant unmet needs in multiple diseases and conditions, including anorexia, cancer, pain, and inflammation. Led by proven biopharmaceutical executives collaborating with highly respected researchers and technology experts, the Company applies leading edge scientific, regulatory, and commercial discipline to develop high-impact therapies.

Investor Contact Information


Artelo Biosciences, Inc.
505 Lomas Santa Fe Drive
Suite 160
Solana Beach, CA 92075

Investor Relations

Crescendo Communications, LLC
T: 212-671-1020

Transfer Agent

American Stock Transfer & Trust Company, LLC
6201 15th Ave
Brooklyn, NY 11219
T: 800-937-5449, 8am-8pm Eastern, M-F